Physician profile
Cindy P Wang
NPI 1649294174
$2,408.54
in general payments reported to CMS, 2019-2025
15 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Pediatrics (Optometrist) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $971 · 2021: $44.38 · 2022: $412 · 2023: $195 · 2024: $234 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615 · Entertainment: $17.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.63 |
| Entertainment | $17.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $950.00 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $456.30 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $206.47 | 2019-2025 | Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $179.59 | 2024-2025 | Xiidra, Miebo, Infuse |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Gilead Sciences, INC. | $117.22 | 2023 | Veklury |
| Biotissue Holdings INC. | $104.47 | 2022 | |
| Visioneering Technologies, INC. | $64.93 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $45.83 | 2025 | Xdemvy |
| Glaukos Corporation | $40.16 | 2022 | |
| Coopervision INC. | $35.14 | 2021-2022 | |
| Allergan, INC. | $26.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.94 | 2022 | |
| Thea Pharma INC. | $19.70 | 2023 | Iyuzeh |
| Optos, INC. | $17.04 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.